0000000000239991

AUTHOR

F.d.a. Aparisi Aparisi

showing 4 related works from this author

1035P Effect of gut microbiota on immunotherapy of advanced NSCLC

2020

Oncologybiologybusiness.industrymedicine.medical_treatmentImmunologymedicineHematologyImmunotherapyGut florabiology.organism_classificationbusinessAnnals of Oncology
researchProduct

1063P Profiling of peripheral T cell receptor beta chain repertoire in non-small cell lung cancer (NSCLC) patients treated with anti-PD1

2020

Oncologybusiness.industryRepertoireCancer researchmedicinenon-small cell lung cancer (NSCLC)HematologyT-Cell Receptor Beta ChainAnti pd1medicine.diseasebusinessPeripheralAnnals of Oncology
researchProduct

1212P Exosomes cargo analysis as an approach to identify new biomarkers in NSCLC

2020

Oncologybusiness.industryCancer researchMedicineHematologybusinessMicrovesiclesAnnals of Oncology
researchProduct

Determination of DPYD polymorphisms before treatment with chemotherapy with a pyrimidine: Should we continue doing it?

2018

Oncologymedicine.medical_specialtyChemotherapyPyrimidinebusiness.industrymedicine.medical_treatmentHematologychemistry.chemical_compoundOncologychemistryInternal medicinemedicineDPYDbusinessAnnals of Oncology
researchProduct